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Gene regulatory networksnderstanding we have for the regulation of skeletal muscle gene expression in
embryos, similar insights into postnatal muscle growth and regeneration are largely inferential or do not
directly address gene regulatory mechanisms. Muscle stem cells (satellite cells) are chieﬂy responsible for
providing new muscle during postnatal and adult life. The purpose of this study was to determine the role
that the myogenic basic helix–loop–helix regulatory factor myogenin has in postnatal muscle growth and
adult muscle stem cell gene expression. We found that myogenin is absolutely required for skeletal muscle
development and survival until birth, but it is dispensable for postnatal life. However, Myog deletion after
birth led to reduced body size implying a role for myogenin in regulating body homeostasis. Despite a lack of
skeletal muscle defects in Myog-deleted mice during postnatal life and the efﬁcient differentiation of
cultured Myog-deleted adult muscle stem cells, the loss of myogenin profoundly altered the pattern of gene
expression in cultured muscle stem cells and adult skeletal muscle. Remarkably, these changes in gene
expression were distinct from those found inMyog-null embryonic skeletal muscle, indicating that myogenin
has separate functions during postnatal life.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe development of vertebrate skeletal muscle begins during
embryonic life and is completed after postnatal growth when an
animal reaches its adult size. In adults, satellite cells (also referred to
as muscle stem cells) recapitulate embryonic myogenesis in a process
that adds and repairs existing muscle ﬁbers (Bischoff, 1994; Charge
and Rudnicki, 2004; Cossu and Molinaro, 1987; Gibson and Schultz,
1983; Schultz et al., 1985). During times of muscle stress or injury,
quiescent satellite cells residing alongside mature myoﬁbers are
activated by external cues to proliferate and differentiate. A recent
intense effort in the muscle research community has been to
understand and eventually manipulate adult muscle stem cells in
ways that will address a wide range of physiological and pathological
problems (Kuang and Rudnicki, 2008).
Once embryonic myogenic precursor cells are speciﬁed to the
myogenic lineage by the expression of the paired-box transcription
factors Pax3 and Pax7, the four basic helix–loop–helix (bHLH)
myogenic regulatory factors (MRFs), Myf5, MyoD, myogenin, and
Mrf4, begin to orchestrate skeletal muscle development. MRFs
cooperate in a synergistic manner with the MEF2 class of proteins
for efﬁcient activation of skeletal muscle target genes (Black and
Olson, 1998). Likewise, adult muscle stem cell differentiation also
appears to be controlled by the MRFs. Much progress has been madey and Molecular Biology, The
ton, TX 77030, USA.
in).
l rights reserved.in distinguishing the roles of individual MRF family members from
each other. While there is a functional redundancy found among the
MRFs, each is conserved among vertebrates and remains efﬁciently
expressed during muscle stem cell proliferation and differentiation
(Sabourin and Rudnicki, 2000). Myf5, MyoD, and Mrf4 function in the
activation of muscle stem cells from the quiescent state and promote
the expression of target genes necessary for muscle stem cell
proliferation (Kablar et al., 1998; Kassar-Duchossoy et al., 2004;
Rudnicki et al., 1993). The differentiation and fusion of embryonic
myoblasts into multinucleated ﬁbers involves myogenin, MyoD, and
Mrf4 (Berkes and Tapscott, 2005; Charge and Rudnicki, 2004),
although it is not yet clear whether these factors have the same role
in adult muscle stem cell differentiation. The genes for each MRF have
been knocked out individually and in combination with other family
members. Notably, Myog-knockout mice exhibit perinatal lethality
caused by a severe disruption of myoblast differentiation and failure to
form normal myoﬁbers (Hasty et al., 1993; Nabeshima et al., 1993). For
postnatal survival, Myog expression levels must equal or exceed the
heterozygous threshold (Venuti et al., 1995; Vivian et al., 1999).
Although myogenin is required for the development of functional
skeletal muscle, it is not required for the expression of all muscle-
expressed genes (Venuti et al., 1995). Furthermore, the expression of
the remainingMRF family members cannot compensate for the lack of
myogenin (Rawls et al., 1995). In a recent study, we analyzed the gene
expression proﬁle of myogenin target genes in embryonic tongue
muscle. The results demonstrated that the expression of many genes
that dependon the presence ofmyogenin are structural components of
the Z-line, which serves as a critical anchor point of the sarcomere, the
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suggest myogenin is necessary for efﬁcient activation of target genes
required for terminal differentiation. Furthermore, MyoD or Myf5,
which are expressed at normal levels in Myog-knockout embryonic
tongue muscle, cannot efﬁciently activate myogenin-dependent genes.
To investigate myogenin's role in postnatal muscle growth, we
generatedMyog conditional knockout mice inwhich efﬁcient deletion
was achieved by tamoxifen-mediated activation of a Cre-ER transgene
(Hayashi and McMahon, 2002; Knapp et al., 2006). When Myog was
deleted at embryonic day 17.5 (E17.5), surviving postnatal mice lacking
myogenin exhibited no apparent defects in muscle morphology or
histology. However, half of all Myog-deleted mice died at birth for
unknown reasons, and the surviving mice were smaller (Knapp et al.,
2006).
In order to better understand the process of skeletal muscle
growth and repair during postnatal and adult life, it is essential to
precisely deﬁne the genetic program under the control of the MRFs
during muscle stem cell proliferation and differentiation. The aim of
this studywas to clarifymyogenin's role in perinatal and postnatal life,
particularly in postnatal muscle growth, and identify the genes whose
expression is controlled by myogenin in adult muscle stem cells. We
show here that myogenin is absolutely essential for skeletal muscle
development and viability until just before birth. However, when
Myogwas deleted 1 day after birth (P1), the mice survived andwe saw
no overt muscle abnormalities, although as observed earlier, Myog-
deleted mice were signiﬁcantly smaller, suggesting a role for
myogenin in regulating body homeostasis. Although skeletal muscle
was superﬁcially normal, major changes in the expression of muscle
genes were found in adult muscle stem cells and muscle of Myog-
deleted mice. Remarkably, these changes in gene expression were
quite different from those identiﬁed in embryonic tongue muscle. The
results conﬁrm and extend our hypothesis that myogenin has distinct
functions as a transcriptional regulator in embryonic myogenesis and
postnatal muscle growth.
Materials and methods
Generation of Myog-deleted mice
The mouse line used for the project was homozygous for the
Myogﬂox allele and hemizygous for the CAGGCre-ER transgene
(Hayashi and McMahon, 2002; Knapp et al., 2006). These mice were
of mixed background, containing both 129 and C57BL/6 strains. All
injections were performed once using tamoxifen (Sigma) at a
concentration of 3 mg/40 g body weight. Pregnant females were
injected intraperitoneally (IP) at either E16.5 or E18.75 of pregnancy.
For postnatal Myog deletion, new born pups at P1 were injected IP.
Weights were measured daily between P5 and P22 and weekly
thereafter. All animal procedures in this study followed the U.S. Public
Health Service Policy on Humane Care and Use of Laboratory Animals
and were approved by the Institutional Animal Care and Use
Committee at The University of Texas M. D. Anderson Cancer Center.
Histology and ﬁber area measurement
New-born mice were embedded in parafﬁn and sectioned for
hematoxylin and eosin staining using previously described methods
(Knapp et al., 2006). Hind limb muscle was used for fresh-frozen
sections by snap freezing the tissue in LN2-cooled isopentane and
sectioning at 10–12 µm with a Cryostat. Student's unpaired t-tests
were performed to determine p-values. Images were taken on a
microscope (Olympus IX70) with an Olympus UPlanApo 10×/0,40
objective lens and camera (Olympus DP71) with Olympus DP-
Controller software. Myoﬁber areas were measured with NIH ImageJ
Software (Abramoff et al., 2004). All muscle ﬁbers visible at 100×
magniﬁcation using gastrocnemius and tibialis anterior muscles from6-week-old mice were measured and the mean and standard
deviations calculated.
DNA isolation and genotyping
DNA was phenol-chloroform extracted from tail or muscle
samples. PCR was performed using the Qiagen HotStarTaq kit on an
ABI Gene AMP PCR system model 9700. Q-PCR was performed using
ABI SYBR mix on an ABI 7500 Fast Real Time PCR system. DNA Primers
and PCR conditions used for genotyping may be obtained by
contacting the corresponding author.
Isolation of muscle stem cells from hind limbs
Muscle stem cells were isolated from hind limb muscle from 6
mice (Myogﬂox/ﬂox; Cre-ER+) 6 to 8 weeks of age using a protocol from
the Pavlath Lab (www.pharm.emory.edu/gpavlath/protocols/
MPCprep0505.pdf). The cells with round morphological characteris-
tics were selected and deﬁned as primitive muscle stem cells (satellite
cells). Images were taken on using a microscope (Leica DMIL) with a
Leica CPlan 10×/0.22 PH1 objective lens and camera (Canon Digital
Rebel XT) with Adobe Photoshop 9.0 software.
Cell culture and tamoxifen treatment
Myogﬂox/ﬂox; Cre-ER+ muscle stem cells were grown to approxi-
mately 75% conﬂuence on a 10 cm plate. Cells proliferated in the
presence of 20% Qualiﬁed FBS (Gibco) and 2.5 ng/ml human bFGF
(Sigma). The cells were then split evenly into 2 new collagen-coated
plates using F-10 growth media. After 24–48 h, the cells attached to
the plates and reached 50% conﬂuence. 4-hydroxy-tamoxifen (4-OHT,
Sigma-Aldrich) was added to fresh growth media to a ﬁnal
concentration of 5 µM 4-OHT, and the cells were incubated for 48 h.
Prior to analysis, the 4-OHT solution was removed and fresh media
added to allow the cells 24 h for treatment recovery. Muscle stem cells
were induced to differentiate by replacing the growth media with
low-serum differentiation media (DMEM supplemented with 2%
horse serum).
Immunoﬂuorescence
Immunoﬂuorescence was performed on muscle stem cells and
NIH-3T3 ﬁbroblast cells and images were collected on an Olympus
FluoView 1000 Confocal Microscope (Olympus IX70) with a UPlanFI
10×/0.30 PH1 objective lens and Olympus FluoView 1000 software.
Controls in which the primary antibody was omitted were used for
each cell line. The cells were cultured for at least 24 h. The slides were
rinsed in PBS, ﬁxed with 4% para-formaldehyde for 30 min, washed
with PBS for 3×5 min, and then permeabilized with PBST (0.5% Triton
X-100 in PBS) for 10 min. After washing in PBS, the cells were treated
with 2% BSA (in PBST) for 1 h. The primary antibodywas then added at
a dilution of 1:200 in PBS for 1 h. Primary antibodies used were c-Met
(Santa Cruz), desmin (Zymed), M-cadherin (Santa Cruz), myogenin
(Santa Cruz), MyoD (Santa Cruz), Pax3/7 (Santa Cruz), and Mhc
(Zymed). The cells were again washed with PBS for 3×5 min and
secondary antibody was then added at 1:400 dilution in PBS for 1 h.
Secondary antibodies used were Cy3 anti-mouse (Jackson Immuno),
Cy5 anti-rabbit (Jackson Immuno), and Alexa488 anti-goat (Molecular
Probes). After incubation with secondary antibody, the cells were
washed with PBS for 3×10 min, and Aqua-Mount was used to mount
the cover slip.
RNA isolation and qRT-PCR
RNAwas isolated from semi-conﬂuent muscle stem cell lines using
either an Invitrogen Trizol protocol or a Qiagen RNeasy Plus kit
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50 µg of RNA. Hind limb tissue was isolated using the Qiagen RNeasy
Plus kit protocol. Reverse transcription and quantitative PCR were
performed as described previously (Davie et al., 2007). The PCR
primers used for detecting the transcripts are available by contacting
the corresponding author. Primers were designed using PrimerBank
(http://pga.mgh.harvard.edu/primerbank). Student's t-tests were
used to determine signiﬁcance between two groups. Statistical
analysis was performed in Microsoft Excel 2003. For all statistical
tests, a conﬁdence level of pb0.05 was accepted as statistically
signiﬁcant. One standard deviation from themeanwas determined for
all comparisons.
Affymetrix gene microarray hybridization and analysis
RNA was isolated from the Myog-deleted and wild-type muscle
stem cells after 48 h of differentiation. Five micrograms of total RNA
from each sample was used for preparing hybridization probes. Three
independent samples were used in standard Affymetrix protocols to
yield ﬂuorescently labeled cRNA fragments, which were hybridized to
Mouse Genome 430 2.0 GeneChips (Affymetrix). The hybridized
GeneChips were scanned using an Affymetrix GeneArray scanner, and
the raw image ﬁles were analyzed using the ArrayAssist 4.0 software
program (Stratagene) with probe logarithmic intensity error normal-
ization (Katz et al., 2006). Unpaired two-class t-tests were performed
without error stabilization or p-value correction and p-value cutoffs
were set at pb0.05. From the ﬁltered data set, all genes changing ≥1.7
fold were kept for further analysis.
In situ hybridization
Twelve-micron fresh-frozen sectionswere obtained fromhind limb
tissue samples dissected from 6-week-old wild-type and Myog-
deleted mice. To generate probes, cDNAs for Adamts5, Sema3d, and
Socs3 (Fantom Clones, Dnaform/Riken) were digested as follows:
Adamts5 (T7), PvuI/NspI; Adamts5 (T3), EagI/PvuI; Sema3d (T7), PvuI/
BamHI; Sema3d (T3), ApaLI/SacII; Socs3 (T7), PvuI/BamHI; Socs3 (T3),
AccI/SspI. Probes for Myog, Ldb3, and Lmod2 were generated as
described previously (Davie et al., 2007). The linearized products
were subsequently transcribed in vitro using T3 RNA polymerase
(antisense probe) and T7 RNA polymerase (sense probe) in the
presence of digoxigenin (Boehringer-Mannheim, Germany). Non-
radioactive in situ hybridization was performed to detect spatial
expression as described previously (Lee et al., 2000). Images were
taken on using a microscope (Olympus IX70) with an OlympusFig. 1. Perinatal diaphragm and intercostal muscle defects and lethality inMyog-deleted P0 m
(B, F) Sagittal section, ventral side. (C, G) Sagittal section, dorsal side. Boxed regions are m
muscles.UPlanApo 10×/0,40 objective lens and camera (Olympus DP71) with
Olympus DP-Controller software.
Statistical analysis
Student's t-tests were used to determine signiﬁcance between two
groups. Statistical analysis was performed inMicrosoft Excel 2003. For
all statistical tests, a conﬁdence level of pb0.05 was accepted as
statistically signiﬁcant. One standard deviation from the mean was
determined for all comparisons.
Results
Myogenin is required for normal perinatal development
We had previously observed that whenMyogwas deleted at E17.5,
only 50% of themice with aMyog-deleted genotypewere born (Knapp
et al., 2006). To determine why so many Myog-deleted mice were not
surviving, pregnant females were injected with tamoxifen at E16.5
and E18.75, and caesarean sections were performed at E19.5. When
tamoxifenwas injected intraperitoneally (IP) at E16.5 and fetuseswere
collected at E19.5, approximately half of the pups from each litter died
within 10 min (Figs. 1A, E). Virtually all of the pups that died harbored
the Cre-ER transgene in their genomes while most of the surviving
pups did not (wild-type n=53;Myog-deleted n=57). Quantitative PCR
genotyping of tail clippings indicated that genomic deletion of Myog
in the dead pups averaged 95% (n=12). Data obtained from our
previous study indicated that Myog deletion levels in tail clippings
and skeletal muscle tissue were very similar (Knapp et al., 2006). The
few surviving Myog-deleted animals were severely growth-stunted
and died within 2 weeks of birth. Similar results were obtained with
the E18.75 tamoxifen treatment (data not shown).
Histological analysis of skeletal muscle from new born (P0) dead
pups and their surviving littermate controls revealed a severe
impairment of skeletal muscle development in the Myog-deleted
pups. Muscles from the diaphragm, deep back, and intercostal ribs
were signiﬁcantly less developed relative to wild-type littermate
controls (Figs. 1B–D, F–H). Myog-deleted pups gasped for air and
responded to pain stimulation similar to littermate controls, but did
not survive beyond 10 min post-caesarean section likely due to severe
diaphragm defects. While Myog-deleted and control P0 pups had
approximately the same body weight and organ size, skeletal muscle
size was reduced dramatically (Figs. 1B–D, F–H). The results extend
our previous analyses (Knapp et al., 2006; Venuti et al., 1995) and
show that an absolute requirement for myogenin extends until justice. (A–D)Wild-type (Myogﬂox/ﬂox); (E–H)Myog-deleted (MyogﬂoxΔ/ﬂoxΔ). (A, E) P0 pups.
agniﬁed in panels D and H. Arrows indicate diaphragms, asterisks indicate intercostal
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mice when Myog is deleted at late stages of myogenesis, between
E16.5 and E18.75. This is a time when secondary myogenesis is
underway, and the results indicated that this period is extremely
sensitive to the presence of myogenin (Venuti et al., 1995; Wigmore
and Dunglison, 1998).
Myogenin is required for achieving normal body size but not for skeletal
muscle growth during postnatal life
We next IP-injected tamoxifen into 1 day old (P1) pups. The pups
we injected were visibly healthy and suckled normally as indicated by
the presence ofmilk in their stomachs.We routinely observed efﬁcient
deletion of Myog within 48–72 h after tamoxifen injection (Knapp et
al., 2006). By P5, all injected pups appeared healthy, and approximately
half had genotypes indicating that, on average, 80% of Myog DNA was
deleted from tail genomic DNA. Genomic DNA levels of Myog in tail
samples were similar to those of hind limb muscle (data not shown)
and served as a viable indicator ofMyog deletion efﬁciency.We did not
determine whether all skeletal muscle tissues were equal in efﬁciency
for deletion events, but deletion events were highly similar in tongue
tissue (data not shown). Between P5 and P22, postnatalMyog-deleted
pups did not gain weight at the same rate as their littermate controls,
and by P22, their average body weight was 20% less than in wild-type
controls (wild-type n=46,Myog-deleted n=33) (Fig. 2A). By 6weeks of
age (P42), the postnatalMyog-deleted animals averaged 37% less body
mass than wild-type littermates (wild-type n=4, Myog-deleted n=4)
(Fig. 2B). These results were consistent with those of our previousFig. 2. PostnatalMyog-deleted mice exhibit decreased growth rate, reduced body mass and n
curve, Myogﬂox/ﬂox) and Myog-deleted (red curve, MyogﬂoxΔ/ﬂoxΔ) mice between P5 and P22. p
wild-type (blue) and Myog-deleted (red) mice at P42 (wild-type, n=4; Myog-deleted, n=4).
n=4; Myog-deleted, n=4). (D) Mean ﬁber area in wild-type and Myog-deleted mice at P42 (w
wild-type (E) and Myog-deleted (F) mice at P42. For panels B–D, the data are represented astudy and suggested that myogenin plays an indirect role in regulating
overall body homeostasis.
Gastrocnemius and tibialis anterior muscles from postnatal Myog-
deleted mice and wild-type controls were examined at P42. Myog
transcript levels in hind limb muscle isolated from the Myog-deleted
mice were, on average, 7% of those in the samemuscle fromwild-type
mice, as determined by quantitative reverse transcriptase-PCR (qRT-
PCR) (Fig. 2C). Histological analysis ofMyog-deleted hind limb muscle
revealed signiﬁcantly smallermyoﬁbers that appeared to organize and
fuse normally with cross-sectional areas reduced by 26% in the
gastrocnemius and tibialis anterior muscles of Myog-deleted mice
relative to those of wild-type littermates (Figs. 2D–F). This reduction
might be expected, since all organs in Myog-deleted mice were
proportionally reduced in size. However, we have not determined
whether the reduced size in other organs was caused by fewer cells or
alternatively, that individual cells were smaller.
Deletion of Myog from adult muscle stem cells
We next determined whether the deletion of Myog in adult
muscle stem cells affected their ability to differentiate into skeletal
muscle or altered their pattern of gene expression. Adult mice
between 6 and 8 weeks of age were sacriﬁced and hind limb muscle
was used for muscle stem cell isolation. The cells were characterized
with the muscle stem cell-speciﬁc markers Pax7, desmin, c-Met, and
M-cadherin to conﬁrm their origins (Allen et al., 1991; Cornelison and
Wold, 1997; Seale et al., 2000) (Fig. S1). To delete Myog, we used the
Cre-Lox system; muscle stem cells were treated with 4-hydroxy-ormal, but proportionally smaller, hind limb muscle. (A) Growth rates of wild-type (blue
-value=2×10−4 at P22 (wild-type, n=46; Myog-deleted, n=33). (B) Mean body mass in
(C) Myog expression in wild-type and Myog-deleted skeletal muscle at P42 (wild-type,
ild-type, n=4; Myog-deleted, n=4). (E, F) Cross sections of gastrocnemius muscle from
s the mean+/−one standard deviation from the mean. ⁎pb0.05.
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S2) and a 91% reduction in Myog transcripts (Fig. 3C).
Myog-deleted muscle stem cells proliferated in culture at the same
rate as wild-type cells (data not shown). Relative expression levels of
Myf5, MyoD, and Mrf4 were analyzed in proliferating wild-type and
Myog-deleted cells. Myf5, MyoD, and Mrf4 showed no signiﬁcant
change in transcript levels despite the large reduction of Myog
transcript levels (Fig. 3C). These results suggested that Myf5, MyoD,
and Mrf4 transcripts were not compensating for the lack of myogenin
as muscle stem cells proliferated in culture.
When wild-type and Myog-deleted muscle stem cells were
induced to differentiate into myotubes, all cell lines that we tested
differentiated normally compared with control cells of the same
genotype but not treated with tamoxifen. Efﬁcient differentiationwas
observed in all the muscle stem cell lines that were established,
indicating that neither the loss of myogenin nor treatment with
tamoxifen affected differentiation (Figs. 3A, B). These results were
consistent with prior studies that showed Myog-null embryonic
myoblasts differentiate normally in culture (Hasty et al., 1993;
Nabeshima et al., 1993).
Immunoﬂuorescencewas performed on themuscle stem cells after
48 h of differentiation to further determine the efﬁciency of
differentiation. In Myog-deleted cells, myogenin protein expression
was signiﬁcantly reduced while the expression of MyoD and desmin,
an indicator of differentiation efﬁciency at the subcellular level,
remained unchanged (Fig. S3).Fig. 3.MRF expression in proliferating and differentiating wild-type and Myog-deleted adul
differentiation. (A)Wild-type (Myogﬂox/ﬂox) and (B)Myog-deleted (MyogﬂoxΔ/ﬂoxΔ) culturedmu
MRF transcript expression in differentiating (48 h) muscle stem cell derivatives. The data are
the mean±one standard deviation from the mean for three independent cell isolates. In pan
genotypes (MyogﬂoxΔ/ﬂoxΔ) are indicated in red. ⁎pb0.05.The relative expression levels of Myf5, MyoD, and Mrf4 were
analyzed in differentiating muscle stem cells. Myog is normally
upregulated at 48 h in embryonic myoblasts differentiating in culture
(Cornelison and Wold, 1997). However, the absence of myogenin at
this critical time point did not affect differentiation, suggesting that
other factors were compensating for the loss of myogenin, perhaps the
remaining MRFs. At 48 h, Myog transcripts in the Myog-deleted cells
were expressed at approximately 14% of the levels found in wild-type
controls. Myf5 and Mrf4 were upregulated approximately 2 fold and
MyoD was upregulated approximately 1.6 fold (Fig. 3D). These results
suggest that compensatory mechanisms may be activated by the
remaining MRFs in the absence of myogenin.
Myogenin is required for efﬁcient expression of many novel genes
expressed during muscle stem cell differentiation
Target genes for myogenin in adult muscle stem cell derivatives
were identiﬁed by Affymetrix microarray analysis using probes from
Myog-deleted and control muscle stem cells at 48 h of differentiation.
The gene set generated from the analysis contained 71 downregulated
genes and 191 upregulated genes with p-valuesb0.05 and fold
changes ≥1.7 (Table S1). Analysis with Array Assist 4.0 revealed that
the expression of typical muscle structural and contractile genes was
unaltered inMyog-deleted cells. This result might be anticipated since
in the absence of myogenin, the cells differentiated efﬁciently into
seemingly normal myotubes. However, it is very different from whatt muscle stem cells. (A, B) Muscle stem cells at 0, 24, 48 h, and 5 days after induction of
scle stem cells. (C) MRF transcript expression in proliferating (0 h)muscle stem cells. (D)
normalized to relative fold changes for Gapdh transcript expression and represented as
els C and D, wild-type genotypes (Myogﬂox/ﬂox) are indicated in blue, and Myog-deleted
Fig. 4. Transcript expression of genes downregulated inMyog-deleted adult muscle stem cell derivatives. The data are normalized to relative fold changes in transcript expression for
Gapdh. Blue bars represent wild-type (Myogﬂox/ﬂox) samples in which the average value of three samples is normalized relative to 1 as indicated on the Y axis. Red bars represent
Myog-deleted (MyogﬂoxΔ/ﬂoxΔ) samples in which the average value of three samples is normalized relative to the wild-type samples. Error bars are one standard deviation from the
mean for three independent cell isolates. Full gene names are given in Table S1 and descriptions are given in Table 1. ⁎pb0.05.
411E. Meadows et al. / Developmental Biology 322 (2008) 406–414we observed with Myog-null embryonic tongue muscle, where most
genes encoding structural and contractile components were strongly
downregulated.
The expression of selected highly deregulated genes, nine down-
regulated genes and seven upregulated genes, was further evaluated
by qRT-PCR for a more accurate quantitative assessment of expression
levels. All of the downregulated genes selected from the microarray
analysis were conﬁrmed as downregulated (Fig. 4). These genes
included those encoding Adamts5 (Schlondorff and Blobel, 1999),
Alcam (van Kempen et al., 2001), CD24a (Figarella-Branger et al., 1993;
Jevsek et al., 2006), Hdac11 (Gao et al., 2002), Itga4 (Yang et al., 1996),
Ptgis (Bondesen et al., 2007; Prisk and Huard, 2003), Sema3d (Kruger
et al., 2005), Socs3 (Spangenburg, 2005), and Sdpr (Gustincich and
Schneider, 1993). A description of these genes is provided in Table 1.Table 1
Description of selected microarray-discovered genes
Gene name FC U/D Gene description
Adamts5 3.1 D Secreted protease; regulates events on or near the cell
surface and at a distance
Alcam 4.2 D Contains immunoglobulin-like domains that regulate
complex cellular properties in cell adhesion, growth,
and migration
CD24a 16.1 D A signal transducing molecule and a marker for human
regenerating muscle
Hdac11 2.1 D Expressed in skeletal muscle
Itga4 9.4 D A receptor that interacts with vascular cell adhesion
molecule 1 and is involved in myogenesis
Ptgis 14.3 D Prostaglandin I2 synthesis (involved in myoblast fusion)
Sema3D 2.7 D Transmembrane signaling protein
Socs3 5.7 D Regulates cytokines and growth factors and induces
myoblast differentiation
Ckmt2 2.3 U Structural component of the sarcomere; creatine
metabolism; regulated in conjunction with the metabolic
energy state of the cell
Itgb1bp3 1.9 U A muscle-speciﬁc beta1 integrin binding protein (MIBP);
negative regulator of myogenic differentiation
Mef2c 1.6 U Myocyte enhancer factor 2c
Spp1 1.5 U Extracellular structural protein found in bone; may
function during the early stages of myogenesis to
facilitate muscle regeneration
Description of selected microarray-discovered genes. Fold change values are data from
qRT-PCR analysis. Gene descriptions are from the indicated references. All references
are given within the text. U/D column indicates whether genes are upregulated or
downregulated.The expression levels of selected upregulated genes were also
determined by qRT-PCR (Fig. S4). These genes include Ckmt2 (Kernec
et al., 2001; Schlattner et al., 2006), Id1, Id2, Id3 (Ruzinova and
Benezra, 2003), integrin beta 1 binding protein 3 (Li et al., 1999), Mef2c
(Martin et al., 1993), and Spp1/osteopontin (Bayless et al., 1998; Hirata
et al., 2003) (Table 1). The genes encoding Ckmt2, integrin beta 1
binding protein 3, Mef2c, and Spp1/osteopontin were conﬁrmed to be
upregulated by this approach. However, the genes encoding Id1, Id2,
and Id3 were not, leaving open the question of the biological
signiﬁcance of their upregulation in the microarray analysis.
We extended our analysis by determining whether the expression
of genes found to be downregulated in culturedMyog-deleted muscle
stem cell derivatives were also downregulated in adult skeletalmuscle
tissue, in vivo. In situ hybridization analysis was performed using hind
limb muscle from 6-week-old wild-type and Myog-deleted mice.
Antisense probes were generated for Adamts5, Sema3d, and Socs3,
three downregulated genes discovered in the microarray analysis.
Myog was included as a control. We also used probes against Lmod2
and Ldb3, two genes previously identiﬁed as downregulated inMyog-
null embryonic tongue muscle but were not downregulated in
cultured adult muscle stem cell derivatives (Davie et al., 2007).
Myog, Adamts5, Sema3d, and Socs3 were all strongly downregulated
in Myog-deleted hind limb muscle while Lmod2 and Ldb3 showed no
changes in gene expression (Fig. 5). These results indicated that
myogenin was regulating distinct gene sets in embryonic versus adult
skeletal muscle.
Discussion
Myogenin's role as a critical regulator of skeletal muscle differ-
entiation and myocyte fusion has been well documented. The present
study, together with previous work, deﬁnes more precisely the period
during embryonic and fetal life when the loss of myogenin leads to
muscle deﬁciency and lethality (Fig. 6). Our results extend earlier
studies to show that myogenin is needed until just before birth.
Skeletal muscle development during the late stages of fetal develop-
ment largely involves the maturation of myoﬁbers, innervation, and
overall muscle growth; these events cannot take place normally
without myogenin. In notable contrast, we found that immediately
following birth, the absence of myogenin had no substantial impact on
the morphology or relative growth of skeletal muscle (Fig. 6). Because
we deletedMyogwithin 24 h after birth, the complications associated
Fig. 5. Myogenin-dependent genes identiﬁed in Myog-deleted adult muscle stem cell derivatives are downregulated in hind limb muscle whereas myogenin-dependent genes
identiﬁed in Myog-null embryonic tongue muscle are not. In situ hybridization analysis reveals downregulated expression of Sema3d, Socs3, Adamts5, and Myog in adult Myog-
deleted (MyogﬂoxΔ/ﬂoxΔ) versus wild-type (Myogﬂox/ﬂox) hind limb muscle. Lmod2 and Ldb3 expression does not change in adultMyog-deleted hind limb muscle. Wild-type genotypes
are indicated in blue, Myog-deleted genotypes are indicated in red.
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development were avoided. These results, therefore, provide a direct
demonstration that myogenin is dispensable for skeletal muscle
growth and survival during postnatal life, a period when the rate of
increase in muscle mass is intense. The ﬁndings are particularly
striking because skeletal muscle mass increases over 10 fold during
the ﬁrst 6 weeks of postnatal life. However, reduced body size was
routinely associated with Myog-deleted mice, suggesting that myo-
genin is affecting overall body homeostasis. BecauseMyog expression
is restricted to the skeletal myogenic lineage, this result implies that
myogenin is playing an indirect role in homeostasis by regulating the
production of skeletal muscle-derived extrinsic factors.Fig. 6. A summary of myogenin's requirement throughout life. Myogenin is essential durin
muscle development but is required for normal body growth. During adult life, where mus
roles in muscle stem cell function and response to muscle stress. Blue lines indicate results f
Green lines and text indicate normal developmental stages of skeletal muscle.Our study also provides new insights into the role of myogenin in
adult muscle stem cells. When Myog-deleted adult muscle stem cells
were induced to differentiate, an upregulation of Myf5, MyoD, and
Mrf4 transcripts were observed. While these results do not directly
demonstrate that the other MRFs were compensating for myogenin's
loss, the fact that they were signiﬁcantly upregulated suggested that
they could be replacing some of myogenin's functions in regulating
muscle gene expression; their increased levels would promote their
ability to bind to myogenin target genes. This ﬁnding is potentially
interesting as it differs from the results obtained using tongue
myocytes in our previous study (Davie et al., 2007) and is consistent
with the notion that myogenin has different functions during adultg embryonic and fetal development. After birth, myogenin is not required for normal
cle is constantly undergoing maintenance and regeneration, myogenin may play direct
rom Myog-null mice while red lines indicate results from postnatal Myog-deleted mice.
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proliferate and differentiate in culture as efﬁciently as wild-type cells,
myogenin was nonetheless found to regulate a distinct set of muscle-
expressed genes. The expression of these myogenin-dependent genes
was dramatically altered in the absence of myogenin. Unlike what was
observed with embryonic myoblasts, many of the myogenin-depen-
dent genes in Myog-deleted adult muscle stem cells encode factors
involved in cell fusion, innervation, or are membrane-associated or
secreted proteins (Tables 1 and S1). We found very few myogenin-
dependent genes encoding structural or contractile proteins. It is
remarkable that although skeletal muscle differentiation proceeds
unabated in cultured muscle stem cells, and skeletal muscle growth is
seemingly normal in postnatal life, the muscle gene expression
program is profoundly altered in the absence of myogenin.
Although our experiments determined the gene expression
proﬁles in muscle stem cells derived from adult mice 6–8 weeks of
age, it is likely that the myogenin-dependent genes we identiﬁed are
the same as those in younger, still-growing mice. The altered
expression of some of these genes at times of active muscle growth
could compromise muscle stem cell function in ways that cause
reduced body size. Compromised muscle stem cell function does in
fact lead to a 77% size reduction in Pax7-null animals by 2 weeks of
age, a 33% reduction in myoﬁber diameters, and results ultimately in
lethality (Seale et al., 2000).
Many of the myogenin-dependent genes identiﬁed in the micro-
array analysis encode proteins with functions that provide insights
into myogenin's role in postnatal skeletal muscle growth. A summary
of these genes and their functions is provided in Table 1. For example,
Adamts5 is a secreted protease that regulates events on or near the
cell surface and at a distance (Nagase and Kashiwagi, 2003;
Schlondorff and Blobel, 1999; Stanton et al., 2005). It was recently
found to be themajor aggrecanase in mouse cartilage, playing a role in
aggrecan loss and cartilage erosion in a mouse model of inﬂammatory
arthritis (Stanton et al., 2005). Myogenin may play a role in the
production of Adamts5 and the regulation of cartilage homeostasis
during adult life. Alcam contains immunoglobulin-like domains that
regulate complex cellular properties in cell adhesion, growth, and
migration. These adhesion molecules play important roles in devel-
opment and homeostasis (van Kempen et al., 2001). CD24 is a signal
transducing molecule and a marker for human regenerating muscle
(Figarella-Branger et al., 1993; Jevsek et al., 2006). Socs3 regulates
cytokines and growth factors (Alexander and Hilton, 2004) and
induces myoblast differentiation (Spangenburg, 2005). Socs3 expres-
sion is partly induced by the activation of the IGF-I receptor during
myoblast differentiation (Spangenburg, 2005). It is possible that
myogenin cooperates with IGF-I to regulate Socs3 expression in newly
developing adult myoﬁbers. It would not be surprising if myogenin
and IGF-I had overlapping functions with respect to Socs3, as IGF-I is a
well-described regulator of skeletal muscle development (Benito et
al., 1996; Kuninger et al., 2004; Spangenburg et al., 2006). Perhaps one
of the most interesting downregulated genes is Ptgis (prostaglandin I2
synthase). Prostaglandins are involved in the repair of muscle injuries
(Prisk and Huard, 2003), and PGI2 (prostaglandin I2) enhances
myoblast fusion in vitro (Pavlath and Horsley, 2003; Bondesen et al.,
2004, 2007). We previously found that myogenin has direct roles in
myoblast fusion (Myer et al., 1997). Myogenin may control the
transcription of Ptgis, which regulates PGI2 synthesis, ultimately
enhancing myoblast fusion and muscle repair. Myogenin also
upregulates the expression of genes whose encoded proteins are
involved in regulating the energy state of the developingmyoﬁber and
in muscle regeneration. Genes encoding proteins with these functions
are described in Table 1.
The mechanistic explanation for the very different functions for
myogenin before and after birth remains unresolved. While it is
possible that these differences are attributed to our comparison of
different muscle groups (tongue versus hind limb), their similarstructural features and functions suggest that they are subject to
comparable developmental regulatory mechanisms. It is possible that
myogenin has critical functions in adult life that will only be revealed
when Myog-deleted mice and Myog-deleted muscle stem cells are
placed under conditions of muscle stress and trauma, which may
demand stronger gene regulatory responses from themuscle stem cell
population than those of mice under no muscle stress.
Acknowledgments
We are grateful for the technical assistance provided by Girard
Courteau Jr and Roberto Reynaga. We thank the M. D. Anderson
Cancer Center shared core DNA Analysis Facility, Genomics Facility,
and Research Animal Support Facility for their assistance. These
facilities are supported in part by a National Cancer Institute
Comprehensive Cancer Center Support Grant (CA16672). The work
was supported by the Muscular Dystrophy Association (MDA4289) to
W.H.K. and by the Robert A. Welch Foundation (G-0010).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.07.024.
References
Abramoff, M.D., et al., 2004. Image processing with Image. J. Biophotonics International
11, 36–42.
Alexander, W.S., Hilton, D.J., 2004. The role of suppressors of cytokine signaling (SOCS)
proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503–529.
Allen, R.E., et al., 1991. Desmin is present in proliferating rat muscle satellite cells but not
in bovine muscle satellite cells. J. Cell Physiol. 149, 525–535.
Bayless, K.J., et al., 1998. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci.
111 (Pt 9), 1165–1174.
Benito, M., et al., 1996. IGF-I: a mitogen also involved in differentiation processes in
mammalian cells. Int. J. Biochem. Cell Biol. 28, 499–510.
Berkes, C.A., Tapscott, S.J., 2005. MyoD and the transcriptional control of myogenesis.
Semin. Cell Dev. Biol. 16, 585–595.
Bischoff, R., 1994. The satellite cell and muscle regeneration. In: Engel, A. (Ed.), Myology,
Vol. 1. Mc-Graw Hill, New York, pp. 97–118.
Black, B.L., Olson, E.N., 1998. Transcriptional control of muscle development by myocyte
enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167–196.
Bondesen, B.A., et al., 2004. The COX-2 pathway is essential during early stages of
skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 287, C475–483.
Bondesen, B.A., et al., 2007. Inhibition of myoblast migration by prostacyclin is
associated with enhanced cell fusion. Faseb J. 21, 3338–3345.
Charge, S.B., Rudnicki, M.A., 2004. Cellular and molecular regulation of muscle
regeneration. Physiol. Rev. 84, 209–238.
Cornelison, D.D., Wold, B.J., 1997. Single-cell analysis of regulatory gene expression in
quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191,
270–283.
Cossu, G., Molinaro, M., 1987. Cell heterogeneity in the myogenic lineage. Curr. Top. Dev.
Biol. 23, 185–208.
Davie, J.K., et al., 2007. Target gene selectivity of the myogenic basic helix–loop–helix
transcription factor myogenin in embryonic muscle. Dev. Biol. 311, 650–664.
Figarella-Branger, D., et al., 1993. CD24, a signal-transducing molecule expressed on
human B lymphocytes, is a marker for human regenerating muscle. Acta.
Neuropathol. (Berl). 86, 275–284.
Gao, L., et al., 2002. Cloning and functional characterization of HDAC11, a novel member
of the human histone deacetylase family. J. Biol. Chem. 277, 25748–25755.
Gibson, M.C., Schultz, E., 1983. Age-related differences in absolute numbers of skeletal
muscle satellite cells. Muscle Nerve 6, 574–580.
Gustincich, S., Schneider, C., 1993. Serum deprivation response gene is induced by
serum starvation but not by contact inhibition. Cell Growth Differ. 4, 753–760.
Hasty, P., et al., 1993. Muscle deﬁciency and neonatal death in mice with a targeted
mutation in the myogenin gene. Nature 364, 501–506.
Hayashi, S., McMahon, A.P., 2002. Efﬁcient recombination in diverse tissues by a
tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/
inactivation in the mouse. Dev. Biol. 244, 305–318.
Hirata, A., et al., 2003. Expression proﬁling of cytokines and related genes in
regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin.
Am. J. Pathol. 163, 203–215.
Jevsek, M., et al., 2006. CD24 is expressed by myoﬁber synaptic nuclei and regulates
synaptic transmission. Proc. Natl. Acad. Sci. U. S. A. 103, 6374–6379.
Kablar, B., et al., 1998. MyoD and Myf-5 deﬁne the speciﬁcation of musculature of
distinct embryonic origin. Biochem. Cell Biol. 76, 1079–1091.
Kassar-Duchossoy, L., et al., 2004. Mrf4 determines skeletal muscle identity in Myf5:
Myod double-mutant mice. Nature 431, 466–471.
414 E. Meadows et al. / Developmental Biology 322 (2008) 406–414Katz, S., et al., 2006. A summarization approach for Affymetrix GeneChip data using a
reference training set from a large, biologically diverse database. BMC Bioinfor-
matics 7, 464.
Kernec, F., et al., 2001. Changes in the mitochondrial proteome from mouse hearts
deﬁcient in creatine kinase. Physiol. Genomics 6, 117–128.
Knapp, J.R., et al., 2006. Loss of myogenin in postnatal life leads to normal skeletal
muscle but reduced body size. Development. 133, 601–610.
Kruger, R.P., et al., 2005. Semaphorins command cells tomove. Nat. Rev. Mol. Cell Biol. 6,
789–800.
Kuang, S., Rudnicki, M.A., 2008. The emerging biology of satellite cells and their
therapeutic potential. Trends Mol. Med. 14, 82–91.
Kuninger, D., et al., 2004. Gene discovery by microarray: identiﬁcation of novel genes
induced during growth factor-mediated muscle cell survival and differentiation.
Genomics 84, 876–889.
Li, J., et al., 1999. A novel muscle-speciﬁc beta 1 integrin binding protein (MIBP) that
modulates myogenic differentiation. J. Cell Biol. 147, 1391–1398.
Lee, J.K., et al., 2000. Expression of neuroD/BETA2 in mitotic and postmitotic neuronal
cells during the development of nervous system. Dev. Dyn. 217, 361–367.
Martin, J.F., et al., 1993. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member
of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. U. S. A. 90,
5282–5286.
Myer, A., et al., 1997. Wild-typemyoblasts rescue the ability of myogenin-null myoblasts
to fuse in vivo. Dev. Biol. 185, 127–138.
Nabeshima, Y., et al., 1993. Myogenin gene disruption results in perinatal lethality
because of severe muscle defect. Nature 364, 532–535.
Nagase, H., Kashiwagi, M., 2003. Aggrecanases and cartilage matrix degradation.
Arthritis Res. Ther. 5, 94–103.
Pavlath, G.K., Horsley, V., 2003. Cell fusion in skeletal muscle—central role of NFATC2 in
regulating muscle cell size. Cell Cycle 2, 420–423.
Prisk, V., Huard, J., 2003. Muscle injuries and repair: the role of prostaglandins and
inﬂammation. Histol. Histopathol. 18, 1243–1256.
Rawls, A., et al., 1995. Myogenin's functions do not overlap with those of MyoD or Myf-5
during mouse embryogenesis. Dev. Biol. 172, 37–50.Rudnicki, M.A., et al., 1993. MyoD or Myf-5 is required for the formation of skeletal
muscle. Cell 75, 1351–1359.
Ruzinova, M.B., Benezra, R., 2003. Id proteins in development, cell cycle and cancer.
Trends Cell Biol. 13, 410–418.
Sabourin, L.A., Rudnicki, M.A., 2000. The molecular regulation of myogenesis. Clin.
Genet. 57, 16–25.
Schlattner, U., et al., 2006. Mitochondrial creatine kinase in human health and disease.
Biochim. Biophys. Acta 1762, 164–180.
Schlondorff, J., Blobel, C.P., 1999. Metalloprotease-disintegrins: modular proteins
capable of promoting cell–cell interactions and triggering signals by protein-
ectodomain shedding. J. Cell Sci. 112 (Pt 21), 3603–3617.
Schultz, E., et al., 1985. Response of satellite cells to focal skeletal muscle injury. Muscle
Nerve 8, 217–222.
Seale, P., et al., 2000. Pax7 is required for the speciﬁcation of myogenic satellite cells.
Cell 102, 777–786.
Spangenburg, E.E., 2005. SOCS-3 induces myoblast differentiation. J. Biol. Chem. 280,
10749–10758.
Spangenburg, E.E., et al., 2006. Exercise increases SOCS-3 expression in rat skeletal
muscle: potential relationship to IL-6 expression. J. Physiol. 572, 839–848.
Stanton, H., et al., 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo
and in vitro. Nature 434, 648–652.
van Kempen, L.C., et al., 2001. Molecular basis for the homophilic activated
leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J. Biol. Chem.
276, 25783–25790.
Venuti, J.M., et al., 1995. Myogenin is required for late but not early aspects of
myogenesis during mouse development. J. Cell Biol. 128, 563–576.
Vivian, J.L., et al., 1999. A hypomorphic myogenin allele reveals distinct myogenin
expression levels required for viability, skeletal muscle development, and sternum
formation. Dev. Biol. 208, 44–55.
Wigmore, P.M., Dunglison, G.F., 1998. The generation of ﬁber diversity during
myogenesis. Int. J. Dev. Biol. 42, 117–125.
Yang, J.T., et al., 1996. Genetic analysis of alpha 4 integrin functions in the development
of mouse skeletal muscle. J. Cell Biol. 135, 829–835.
